Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Corteva to acquire Stoller for $1.2bn in deal seen as an 'opening salvo'

Published 30/11/2022, 19:18
Updated 30/11/2022, 19:18
© Reuters.

© Reuters.

By Sam Boughedda

Corteva (NYSE:CTVA) announced before the open on Wednesday that it has agreed on a deal to acquire Houston-based Stoller for $1.2 billion in cash.

Corteva told investors that Stoller brings in global sales of over $400 million and a presence in more than 60 countries while reinforcing the firm's commitment to "driving value for farmers through innovative, sustainable solutions."

The deal represents the second Biologicals acquisition for Corteva this year after it recently announced it has signed a definitive agreement to acquire Symborg.

Corteva anticipates the deal will be completed in the first half of 2023.

Reacting to the news, Morgan Stanley analysts said the firm sees Stoller "as a strategic - immediately accretive - acquisition at a reasonable price that positions the company well to build out further in biologicals through Corteva led initiatives, Stoller's products/footprint, as well as the recently announced Symborg acquisition."

"We also view it as the opening salvo in the company putting its under-levered balance sheet to work - a key driver of our bull case," added the analysts, who have an Overweight rating and a $70 per share price target on the stock.

Elsewhere, Mizuho analysts have a Buy rating and a $76 price target on Corteva.

They said in a note: "Our knee-jerk reaction is this deal is consistent with CTVA's stated goals to bring complementary biologicals technologies in-house to align the portfolio with expected industry growth over the next decade-plus (expect biologicals to grow at HSD CAGR and represent 25% of CPC market by 2035) - though this deal is larger than many were expecting."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.